Camp4 Therapeutics will host a virtual Analyst Day on Sept. 28 to outline the clinical path for its regRNA-based SYNGAP1 program. The company said it will discuss Phase 1/2 plans for its lead candidate and hold a live Q&A.
published
Camp4 Therapeutics will host a virtual Analyst Day on Sept. 28 to outline the clinical path for its regRNA-based SYNGAP1 program. The company said it will discuss Phase 1/2 plans for its lead candidate and hold a live Q&A.
Latest documented BWB result
$META market result
I sold the $META $655 Puts 9/25 for $7.60
Historical results are not a promise of future performance. Trading involves substantial risk.This public post is a timestamped information archive, not personalized financial advice. Alerts can change as markets move. Join Billy's private group for the complete daily stream and follow-through.